SV Life Sciences Raises Over US $523 Million for Fifth Fund, SV Life Sciences Fund V
BOSTON, SAN FRANCISCO, and LONDON, June 29 /PRNewswire/ -- SV Life Sciences (SVLS) today announced the final closing of its newest fund – SV Life Sciences Fund V (SVLSF V). The fund closed with total commitments of over $523 million, well exceeding its target of $400 million.

New ARX Partner Provides Validation Services for CoSign Life Science Installations
ARX, the leading digital signature solution provider in the Life Sciences industry, teams up with Montrium to provide validation packages equipped with CoSign® digital signatures.

Pluromed, Inc. Announces FDA Approval for BackStop™
Pluromed, Inc. announced approval by the U.S. Food and Drug Administration (FDA) for BackStop™ (http://pluromed.com/products_top.htm), a device used in ureteroscopic kidney stone management procedures. BackStop was approved as a Class II device under the pre-market notification 510(k) process.

Caliper Life Sciences to Present at Jefferies 2010 Global Life Sciences Conference
HOPKINTON, Mass., June 2 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced that its presentation at the Jefferies 2010 Global Life Sciences Conference, will be webcast on Friday, June 11 at 12:45 p.m.